The overarching goal of Dr. Dahne's research program is to significantly reduce the public health impact of combustible tobacco use among populations with elevated smoking rates (e.g., socioeconomically disadvantaged smokers, smokers with mental health comorbidities). The majority of Dr. Dahne's work centers around development and evaluation of technology-based remote interventions for the treatment of smoking cessation and common comorbidities (e.g., depression) as well as methods to improve the feasibility and rigor of remote trials. Her current research project aims to extend the reach of evidence-based smoking cessation treatment by leveraging proactive outreach within the primary care setting. Her multidisciplinary team will examine both the effectiveness and the implementation potential of a proactive electronic visit, delivered via the Electronic Health Record, for smoking cessation across a diverse network of primary care, family medicine, and internal medicine clinics. Dr. Dahne first became interested in this field of research while working at the Center for Addiction and Pregnancy at Johns Hopkins Bayview Medical Center as an undergraduate student. During that experience, she was struck by the enduring negative health impacts of combustible tobacco use and limited access to evidence-based cessation resources for populations most likely to smoke.